中华皮肤科杂志 ›› 2022, Vol. 55 ›› Issue (11): 939-949.doi: 10.35541/cjd.20220420
中国医疗保健国际交流促进会皮肤科分会 国家皮肤与免疫疾病临床医学研究中心
收稿日期:2022-06-13
修回日期:2022-08-03
发布日期:2022-11-03
通讯作者:
晋红中；陆前进
E-mail:jinhongzhong@263.net; qianlu5860@ pumcderm.cams.cn
基金资助:Dermatology Branch of China International Exchange and Promotive Association for Medical and Health Care; National Clinical Research Center for Dermatologic and Immunologic Diseases
Received:2022-06-13
Revised:2022-08-03
Published:2022-11-03
Contact:
Jin Hongzhong; Lu Qianjin
E-mail:jinhongzhong@263.net; qianlu5860@ pumcderm.cams.cn
Supported by:摘要： 【摘要】 皮肌炎是一种特发性炎性肌病，可出现典型皮损、近端肌无力和多器官受累表现，亦可伴发恶性肿瘤。中国医疗保健国际交流促进会皮肤科分会、国家皮肤与免疫疾病临床医学研究中心以国内外成人皮肌炎诊断和治疗的相关文献和专家建议作为依据，制定成人皮肌炎诊疗共识，供各级皮肤科及其他相关科室医师参考。
中国医疗保健国际交流促进会皮肤科分会 国家皮肤与免疫疾病临床医学研究中心. [开放获取] 成人皮肌炎诊疗中国专家共识（2022年）[J]. 中华皮肤科杂志, 2022,55(11):939-949. doi:10.35541/cjd.20220420
Dermatology Branch of China International Exchange and Promotive Association for Medical and Health Care, National Clinical Research Center for Dermatologic and Immunologic Diseases. Chinese Expert consensus on the diagnosis and treatment of adult dermatomyositis （2022）[J]. Chinese Journal of Dermatology, 2022, 55(11): 939-949.doi:10.35541/cjd.20220420
| ［1］ | Lundberg IE, Fujimoto M, Vencovsky J, et al. Idiopathic inflammatory myopathies［J］. Nat Rev Dis Primers, 2021,7（1）:86. doi: 10.1038/s41572⁃021⁃00321⁃x. |
| ［2］ | Schlecht N, Sunderkötter C, Niehaus S, et al. Update on dermatomyositis in adults［J］. J Dtsch Dermatol Ges, 2020,18（9）:995⁃1013. doi: 10.1111/ddg.14267. |
| ［3］ | DeWane ME, Waldman R, Lu J. Dermatomyositis: clinical features and pathogenesis［J］. J Am Acad Dermatol, 2020,82（2）:267⁃281. doi: 10.1016/j.jaad.2019.06.1309. |
| ［4］ | Quinter SD, Chiu YE, Lyon VB, et al. Inverse Gottron′s papules: an unusual cutaneous manifestation of juvenile dermatomyositis［J］. Pediatr Dermatol, 2012,29（5）:641⁃644. doi: 10.1111/j.1525⁃1470.2011.01585.x. |
| ［5］ | Cao H, Xia Q, Pan M, et al. Gottron papules and Gottron sign with ulceration: a distinctive cutaneous feature in a subset of patients with classic dermatomyositis and clinically amyopathic dermatomyositis［J］. J Rheumatol, 2016,43（9）:1735⁃1742. doi: 10.3899/jrheum.160024. |
| ［6］ | Xu X, Chen B, Huang J, et al. Seborrheic dermatitis⁃distributed rash in dermatomyositis is associated with progressive interstitial lung disease［J］. J Am Acad Dermatol, 2021,84（6）:1694⁃1696. doi: 10.1016/j.jaad.2020.12.021. |
| ［7］ | Xu X, Huang J, Wang X, et al. Pseudoangioedema in dermatomyositis patients indicates severe disease and poor prognosis［J］. J Am Acad Dermatol, 2022,86（2）:474⁃475. doi: 10.1016/j.jaad.2021.09.043. |
| ［8］ | 中华医学会风湿病学分会. 多发性肌炎和皮肌炎诊断及治疗指南［J］. 中华风湿病学杂志, 2010,14（12）:828⁃831. doi: 10.3760/cma.j.issn.1007⁃7480.2010.12.008. |
| ［9］ | Connors GR, Christopher⁃Stine L, Oddis CV, et al. Interstitial lung disease associated with the idiopathic inflammatory myopathies: what progress has been made in the past 35 years?［J］. Chest, 2010,138（6）:1464 ⁃ 1474. doi: 10.1378/chest.10⁃0180. |
| ［10］ | 孙宇新, 张泽煜, 邵池, 等. 抗黑色素瘤分化相关基因5抗体相关性快速进展性间质性肺疾病的诊治进展［J］. 中华结核和呼吸杂志, 2021,44（9）:837⁃839. doi: 10.3760/cma.j.cn112147⁃20201105⁃01083. |
| ［11］ | Danieli MG, Gelardi C, Guerra F, et al. Cardiac involvement in polymyositis and dermatomyositis［J］. Autoimmun Rev, 2016,15（5）:462⁃465. doi: 10.1016/j.autrev.2016.01.015. |
| ［12］ | Ungprasert P, Suksaranjit P, Spanuchart I, et al. Risk of coronary artery disease in patients with idiopathic inflammatory myopathies: a systematic review and meta ⁃ analysis of observational studies［J］. Semin Arthritis Rheum, 2014,44（1）:63⁃67. doi: 10.1016/j.semarthrit.2014.03.004. |
| ［13］ | Ghate J, Katsambas A, Augerinou G, et al. Review article: a therapeutic update on dermatomyositis/polymyositis［J］. Int J Dermatol, 2000,39（2）:81⁃87. doi: 10.1046/j.1365⁃4362.2000. 00851.x. |
| ［14］ | Yang Z, Lin F, Qin B, et al. Polymyositis/dermatomyositis and malignancy risk: a metaanalysis study［J］. J Rheumatol, 2015,42（2）:282⁃291. doi: 10.3899/jrheum.140566. |
| ［15］ | Wang J, Guo G, Chen G, et al. Meta⁃analysis of the association of dermatomyositis and polymyositis with cancer［J］. Br J Dermatol, 2013,169（4）:838⁃847. doi: 10.1111/bjd.12564. |
| ［16］ | Ghirardello A, Bassi N, Palma L, et al. Autoantibodies in polymyositis and dermatomyositis［J］. Curr Rheumatol Rep, 2013,15（6）:335. doi: 10.1007/s11926⁃013⁃0335⁃1. |
| ［17］ | Gono T, Kawaguchi Y, Hara M, et al. Increased ferritin predicts development and severity of acute interstitial lung disease as a complication of dermatomyositis［J］. Rheumatology （Oxford）, 2010,49（7）:1354⁃1360. doi: 10.1093/rheumatology/keq073. |
| ［18］ | Kohsaka H, Mimori T, Kanda T, et al. Treatment consensus for management of polymyositis and dermatomyositis among rheumatologists, neurologists and dermatologists［J］. Mod Rheumatol, 2019,29（1）:1⁃19. doi: 10.1080/14397595.2018.152 1185. |
| ［19］ | Sasaki H, Kohsaka H. Current diagnosis and treatment of polymyositis and dermatomyositis［J］. Mod Rheumatol, 2018,28（6）:913⁃921. doi: 10.1080/14397595.2018.1467257. |
| ［20］ | Mammen AL, Allenbach Y, Stenzel W, et al. 239th ENMC International Workshop: classification of dermatomyositis, Amsterdam, the Netherlands, 14 ⁃ 16 December 2018［J］. Neuromuscul Disord, 2020,30（1）:70 ⁃ 92. doi: 10.1016/j.nmd.2019.10.005. |
| ［21］ | Waldman R, DeWane ME, Lu J. Dermatomyositis: diagnosis and treatment［J］. J Am Acad Dermatol, 2020,82（2）:283⁃296. doi: 10.1016/j.jaad.2019.05.105. |
| ［22］ | Gono T, Kuwana M. Current understanding and recent advances in myositis⁃specific and ⁃associated autoantibodies detected in patients with dermatomyositis［J］. Expert Rev Clin Immunol, 2020,16（1）:79⁃89. doi: 10.1080/1744666X.2019.1699059. |
| ［23］ | Sunderkötter C, Nast A, Worm M, et al. Guidelines on dermatomyositis⁃excerpt from the interdisciplinary S2k guidelines on myositis syndromes by the German Society of Neurology［J］. J Dtsch Dermatol Ges, 2016,14（3）:321⁃338. doi: 10.1111/ddg. 12909. |
| ［24］ | 王子璇, 宋小慧, 胡赟赟, 等. 特发性炎症性肌病肌肉病变的诊断及活动度评估［J］. 中国皮肤性病学杂志, 2022,36（7）:733⁃738. doi: 10.13735/j.cjdv.1001⁃7089.202110044. |
| ［25］ | 李霞, 丁晓毅, 郑捷. MRI诊断皮肌炎与多发性肌炎的探讨［J］. 诊断学理论与实践, 2004,3（4）:257⁃259. doi: 10.16150/j.1671⁃2870.a1978. |
| ［26］ | Bohan A, Peter JB. Polymyositis and dermatomyositis（first of two parts）［J］. N Engl J Med, 1975,292（7）:344⁃347. doi: 10.1056/NEJM197502132920706. |
| ［27］ | Lundberg IE, Tjärnlund A, Bottai M, et al. 2017 European League Against Rheumatism/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups［J］. Arthritis Rheumatol, 2017,69（12）:2271⁃2282. doi: 10.1002/art.40320. |
| ［28］ | Sontheimer RD. Dermatomyositis: an overview of recent progress with emphasis on dermatologic aspects［J］. Dermatol Clin, 2002,20（3）:387⁃408. doi: 10.1016/s0733⁃8635（02）00021⁃9. |
| ［29］ | 中国医师协会皮肤科医师分会自身免疫性疾病亚专业委员会. 糖皮质激素治疗免疫相关性皮肤病专家共识（2018年）［J］. 中华临床免疫和变态反应杂志, 2018,12（1）:1⁃7. doi:10.3969/j.issn.1673⁃8705.2018.01.001. |
| ［30］ | Hoff LS, de Souza F, Miossi R, et al. Long⁃term effects of early pulse methylprednisolone and intravenous immunoglobulin in patients with dermatomyositis and polymyositis ［J］. Rheumatology（Oxford）, 2022,61（4）:1579⁃1588. doi: 10.1093/rheumatology/keab597. |
| ［31］ | Villalba L, Hicks JE, Adams EM, et al. Treatment of refractory myositis: a randomized crossover study of two new cytotoxic regimens［J］. Arthritis Rheum, 1998,41（3）:392 ⁃ 399. doi: 10.1002/1529⁃0131（199803）41:3<392::AID⁃ART3>3.0.CO;2⁃X. |
| ［32］ | 卢紫函, 陈衍安, 郑敏. JAK抑制剂治疗难治性皮肌炎的研究进展［J］. 中国皮肤性病学杂志, 2022,36（5）:599⁃602. doi: 10.13735/j.cjdv.1001⁃7089.202101167. |
| ［33］ | Sato S, Kuwana M. Clinically amyopathic dermatomyositis［J］. Curr Opin Rheumatol, 2010,22（6）:639⁃643. doi: 10.1097/BOR.0b013e32833f1987. |
| ［34］ | Grinnell M, Keyes E, Diaz D, et al. Mycophenolate mofetil and methotrexate efficacy in dermatomyositis［J］. Br J Dermatol, 2022. doi: 10.1111/bjd.21235. |
| ［35］ | Mainetti C, Terziroli Beretta ⁃ Piccoli B, Selmi C. Cutaneous manifestations of dermatomyositis: a comprehensive review［J］. Clin Rev Allergy Immunol, 2017,53（3）:337⁃356. doi: 10. 1007/s12016⁃017⁃8652⁃1. |
| ［36］ | Tang K, Zhang H, Jin H. Clinical characteristics and management of patients with clinical amyopathic dermatomyositis: a retrospective study of 64 patients at a tertiary dermatology department［J］. Front Med （Lausanne）, 2021,8:783416. doi: 10.3389/fmed.2021.783416. |
| ［37］ | Chen Z, Wang X, Ye S. Tofacitinib in amyopathic dermatomyositis⁃associated interstitial lung disease［J］. N Engl J Med, 2019,381（3）:291⁃293. doi: 10.1056/NEJMc1900045. |
| ［38］ | Munira S, Christopher⁃Stine L. Pregnancy in myositis and scleroderma［J］. Best Pract Res Clin Obstet Gynaecol, 2020,64:59⁃67. doi: 10.1016/j.bpobgyn.2019.10.004. |
| ［39］ | Tang K, Zhou J, Lan Y, et al. Pregnancy in adult⁃onset dermatomyositis/polymyositis: a systematic review［J］. Am J Reprod Immunol, 2022: e13603. doi: 10.1111/aji.13603 |
| ［40］ | Meisterfeld S, Röber N, Conrad K, et al. A chronic recurrent disease course of dermatomyositis is associated with autoantibodies against transcriptional intermediary factor 1 ⁃ γ［J］. Br J Dermatol, 2017,177（2）:590 ⁃ 593. doi: 10.1111/bjd. 15468. |
| [1] | 雷杰豪 洪为松 林福全 胡文婷 许爱娥. 体外培养节段型白癜风样无色素痣皮损黑素细胞及其临床意义[J]. 中华皮肤科杂志, 2022, 55(9): 798-802. |
| [2] | 樊碧娆 陈喜雪 王明悦. [开放获取] 米诺环素单药或联合小剂量糖皮质激素治疗红斑型天疱疮15例和疱疹样天疱疮9例疗效和安全性回顾分析[J]. 中华皮肤科杂志, 2022, 55(8): 676-681. |
| [3] | 曹淼 崇杉 胡新媛 朱学骏 王明悦. 副肿瘤性天疱疮患者原发肿瘤切除后皮肤黏膜感染及管理分析[J]. 中华皮肤科杂志, 2022, 55(8): 669-675. |
| [4] | 晋亮 刘玲. 部分遗传性皮肤病的治疗进展[J]. 中华皮肤科杂志, 2022, 55(8): 735-739. |
| [5] | 徐哲. 对遗传性皮肤病的一些思考[J]. 中华皮肤科杂志, 2022, 55(8): 651-652. |
| [6] | 王媛 李志量 李锁 荆可 孙超 梁桂熔 张寒梅 冯素英. 抗p200类天疱疮7例临床及免疫血清学特征分析[J]. 中华皮肤科杂志, 2022, 55(7): 557-561. |
| [7] | 高子蕊 赵培 窦沅青 刘萍 张建中. 度普利尤单抗治疗成人结节性痒疹的疗效与安全性观察[J]. 中华皮肤科杂志, 2022, 55(7): 562-565. |
| [8] | 王玲艳 潘靖 苗钢 常晓丹 金秋子 郭宁宁 张佳钰. 对生物制剂治疗抵抗的银屑病患者皮损部位分析[J]. 中华皮肤科杂志, 2022, 55(7): 583-587. |
| [9] | 吕莎 王爽 武寒飞 张明瑞 胡馨 李福秋. 孢子丝菌病研究进展[J]. 中华皮肤科杂志, 2022, 55(7): 629-632. |
| [10] | 张诗敏 胡赟赟 赵肖庆 杜联军 曹华 郑捷. 影像技术在皮肌炎诊断和病情评估中的研究进展[J]. 中华皮肤科杂志, 2022, 55(7): 637-640. |
| [11] | 张宁 李舒 李敬. 免疫检查点抑制剂和靶向药物辅助治疗可切除黑素瘤疗效的网状Meta分析[J]. 中华皮肤科杂志, 2022, 55(7): 603-609. |
| [12] | 中华医学会皮肤性病学分会特应性皮炎研究中心 中华医学会皮肤性病学分会儿童学组. 【开放获取】度普利尤单抗治疗特应性皮炎专家共识[J]. 中华皮肤科杂志, 2022, 55(6): 465-470. |
| [13] | 中国医师协会皮肤科医师分会自身免疫病专业委员会 . 【开放获取】环孢素治疗免疫相关性皮肤病专家建议[J]. 中华皮肤科杂志, 2022, 55(6): 471-479. |
| [14] | 赵柳琦 陈妍 陈丹阳 樊碧娆 王瑞 尚盼盼 陈喜雪 朱学骏 王明悦. 【开放获取】度普利尤单抗治疗大疱性类天疱疮21例的疗效及安全性回顾分析[J]. 中华皮肤科杂志, 2022, 55(6): 480-485. |
| [15] | 黄馨 陈筱昀 李亚萍 梁兴堃 张桂英 周英 湛意 罗帅寒天 廖洁月 肖嵘 龙海. 度普利尤单抗治疗123例特应性皮炎的疗效及安全性分析[J]. 中华皮肤科杂志, 2022, 55(6): 486-493. |
|
